These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9044506)

  • 1. Molecular pathology of posttransplantation lymphoproliferative disorders.
    Chadburn A; Cesarman E; Knowles DM
    Semin Diagn Pathol; 1997 Feb; 14(1):15-26. PubMed ID: 9044506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders.
    Knowles DM; Cesarman E; Chadburn A; Frizzera G; Chen J; Rose EA; Michler RE
    Blood; 1995 Jan; 85(2):552-65. PubMed ID: 7812011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome.
    Cesarman E; Chadburn A; Liu YF; Migliazza A; Dalla-Favera R; Knowles DM
    Blood; 1998 Oct; 92(7):2294-302. PubMed ID: 9746767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetic analysis demonstrates that multiple posttransplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms.
    Chadburn A; Cesarman E; Liu YF; Addonizio L; Hsu D; Michler RE; Knowles DM
    Cancer; 1995 Jun; 75(11):2747-56. PubMed ID: 7743481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.
    Scheinfeld AG; Nador RG; Cesarman E; Chadburn A; Knowles DM
    Am J Pathol; 1997 Sep; 151(3):805-12. PubMed ID: 9284829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
    Quintanilla-Martínez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F
    Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders.
    Nador RG; Chadburn A; Gundappa G; Cesarman E; Said JW; Knowles DM
    Am J Surg Pathol; 2003 Mar; 27(3):293-302. PubMed ID: 12604885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant.
    Chadburn A; Chen JM; Hsu DT; Frizzera G; Cesarman E; Garrett TJ; Mears JG; Zangwill SD; Addonizio LJ; Michler RE; Knowles DM
    Cancer; 1998 May; 82(10):1978-87. PubMed ID: 9587133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features.
    Orazi A; Hromas RA; Neiman RS; Greiner TC; Lee CH; Rubin L; Haskins S; Heerema NA; Gharpure V; Abonour R; Srour EF; Cornetta K
    Am J Clin Pathol; 1997 Apr; 107(4):419-29. PubMed ID: 9124210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
    Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
    Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
    Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
    Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation.
    Armes JE; Angus P; Southey MC; Battaglia SE; Ross BC; Jones RM; Venter DJ
    Cancer; 1994 Nov; 74(9):2436-41. PubMed ID: 7922997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunodeficiency-associated lymphoproliferative disorders.
    Knowles DM
    Mod Pathol; 1999 Feb; 12(2):200-17. PubMed ID: 10071343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus.
    Frank D; Cesarman E; Liu YF; Michler RE; Knowles DM
    Blood; 1995 Mar; 85(5):1396-403. PubMed ID: 7858270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p16/INK4a in posttransplantation lymphoproliferative disorders.
    Martin A; Baran-Marzak F; El Mansouri S; Legendre C; Leblond V; Charlotte F; Davi F; Canioni D; Raphaël M
    Am J Pathol; 2000 May; 156(5):1573-9. PubMed ID: 10793069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients.
    Wu TT; Swerdlow SH; Locker J; Bahler D; Randhawa P; Yunis EJ; Dickman PS; Nalesnik MA
    Hum Pathol; 1996 Feb; 27(2):157-64. PubMed ID: 8617457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin.
    Chadburn A; Suciu-Foca N; Cesarman E; Reed E; Michler RE; Knowles DM
    Am J Pathol; 1995 Dec; 147(6):1862-70. PubMed ID: 7495309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated, multiclonal Epstein-Barr virus-associated lymphoproliferative disease in a patient with hematological and immunological anomalies. Molecular analysis correlates with morphological appearance.
    Armes JE; Eades S; Southey MC; Ross BC; Carapetis JR; Chow CW; Venter DJ
    Diagn Mol Pathol; 1995 Mar; 4(1):39-47. PubMed ID: 7735554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma.
    Dojcinov SD; Venkataraman G; Pittaluga S; Wlodarska I; Schrager JA; Raffeld M; Hills RK; Jaffe ES
    Blood; 2011 May; 117(18):4726-35. PubMed ID: 21385849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristic pattern of chromosomal imbalances in posttransplantation lymphoproliferative disorders: correlation with histopathological subcategories and EBV status.
    Poirel HA; Bernheim A; Schneider A; Meddeb M; Choquet S; Leblond V; Charlotte F; Davi F; Canioni D; Macintyre E; Mamzer-Bruneel MF; Hirsch I; Hermine O; Martin A; Cornillet-Lefebvre P; Patey M; Toupance O; Kémény JL; Deteix P; Raphaël M
    Transplantation; 2005 Jul; 80(2):176-84. PubMed ID: 16041261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.